19 insiders reported 114 Form 4 transactions for REGENERON PHARMACEUTICALS, INC. (REGN) over the past 18 months (most recent 2026-07-07). Recent activity: RYAN ARTHUR F (Director) Sell 200 shares, RYAN ARTHUR F (Director) Sell 1 shares, RYAN ARTHUR F (Director) Sell 3 shares, RYAN ARTHUR F (Director) Sell 8 shares, RYAN ARTHUR F (Director) Sell 8 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-07 | RYAN ARTHUR F | Director | Sell | 200 | $130,030 |
| 2026-04-03 | RYAN ARTHUR F | Director | Sell | 1 | $771 |
| 2026-04-03 | RYAN ARTHUR F | Director | Sell | 3 | $2,318 |
| 2026-04-03 | RYAN ARTHUR F | Director | Sell | 8 | $6,189 |
| 2026-04-03 | RYAN ARTHUR F | Director | Sell | 8 | $6,197 |
| 2026-04-03 | RYAN ARTHUR F | Director | Sell | 14 | $10,858 |
| 2026-04-03 | RYAN ARTHUR F | Director | Sell | 13 | $10,096 |
| 2026-04-03 | RYAN ARTHUR F | Director | Sell | 9 | $6,997 |
| 2026-04-03 | RYAN ARTHUR F | Director | Sell | 4 | $3,113 |
| 2026-04-03 | RYAN ARTHUR F | Director | Sell | 40 | $31,188 |
| 2026-03-03 | RYAN ARTHUR F | Director | Sell | 20 | $15,779 |
| 2026-03-03 | RYAN ARTHUR F | Director | Sell | 2 | $1,557 |
| 2026-03-03 | RYAN ARTHUR F | Director | Sell | 5 | $3,898 |
| 2026-03-03 | RYAN ARTHUR F | Director | Sell | 3 | $2,342 |
| 2026-03-03 | RYAN ARTHUR F | Director | Sell | 2 | $1,562 |
| 2026-03-03 | RYAN ARTHUR F | Director | Sell | 2 | $1,565 |
| 2026-03-03 | RYAN ARTHUR F | Director | Sell | 10 | $7,836 |
| 2026-03-03 | RYAN ARTHUR F | Director | Sell | 9 | $7,060 |
| 2026-03-03 | RYAN ARTHUR F | Director | Sell | 11 | $8,640 |
| 2026-03-03 | RYAN ARTHUR F | Director | Sell | 7 | $5,506 |
| 2026-03-03 | RYAN ARTHUR F | Director | Sell | 2 | $1,575 |
| 2026-03-03 | RYAN ARTHUR F | Director | Sell | 7 | $5,442 |
| 2026-03-03 | RYAN ARTHUR F | Director | Sell | 20 | $15,786 |
| 2026-02-23 | Zoghbi Huda Y | Director | Buy | 1,638 | $617,018 |
| 2026-02-23 | Zoghbi Huda Y | Director | Sell | 49 | $37,959 |
Source: SEC Form 4 filings · as of 2026-07-07